Literature DB >> 1259393

Clinical pharmacology of cefamandole as compared with cephalothin.

I W Fong, E D Ralph, E R Engelking, W M Kirby.   

Abstract

We compared the pharmacology of cefamandole and cephalothin in six healthy adult male volunteers. After a 1-g, 20-min intravenous (i.v.) infusion, the average peak blood level of cefamandole was 87.6 versus 64.1 mug/ml for cephalothin. An i.v. infusion of 500 mg/h for 2 h (after a loading dose of 750 mg) gave an average steady-state blood level of 28.5 mug/ml for cefamandole and 18.2 mug/ml for cephalothin. Mean peak serum levels after 1 g intramuscularly were similar for the two antibiotics (about 21 mug/ml), but with cefamandole they persisted longer, and the area under the blood level curve was about 25% greater. The average t((1/2)) as determined from both i.v. studies was 34 min for cefamandole versus 30 min for cephalothin. The mean serum clearance for cephalothin, due to its partial conversion to a metabolite, was much greater than for cefamandole (425 versus 272 ml/min per 1.73 m(2)), but the renal clearances were similar for the two antibiotics (268 versus 257 ml/min per 1.73 m(2)). Other values for cefamandole and cephalothin were: 24-h urinary excretion, 80 and 66%; serum protein binding, 74 and 70%; and apparent volume of distribution, 12.8 and 18.5 liters/1.73 m(2), respectively. Thus, the pharmacology of the two antibiotics was similar. Blood levels were somewhat higher with cefamandole i.v., but the results suggest that dosage regimens should be the same for the two antibiotics.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1259393      PMCID: PMC429475          DOI: 10.1128/AAC.9.1.65

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Pharmacokinetics of parenteral sodium cephalexin in comparison with cephalothin and cefazolin.

Authors:  C Regamey; R D Libke; J T Clarke; W M Kirby
Journal:  Infection       Date:  1974       Impact factor: 3.553

2.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

3.  A rapid, modified ultrafiltration method for determining serum protein binding and its application to new penicillins.

Authors:  J V Bennett; W M Kirby
Journal:  J Lab Clin Med       Date:  1965-11

4.  Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

5.  Excretion of cephaloridine and cephalothin in patients with renal impairment.

Authors:  C M Kunin; N Atuk
Journal:  N Engl J Med       Date:  1966-03-24       Impact factor: 91.245

6.  Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.

Authors:  S Eykyn; C Jenkins; A King; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191

  6 in total
  20 in total

1.  Penetration of cefamandole into spinal fluid.

Authors:  E A Steinberg; G D Overturf; L J Baraff; J Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

2.  Effect of probenecid on the blood levels and urinary excretion of cefamandole.

Authors:  R S Griffith; H R Black; G L Brier; J D Wolny
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

3.  Pharmacokinetics of cefamandole in patients undergoing hemodialysis and peritoneal dialysis.

Authors:  M J Ahern; F O Finkelstein; V T Andriole
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

4.  Comparative pharmacokinetics of cefamandole, cephapirin, and cephalothin in healthy subjects and effect of repeated dosing.

Authors:  M Barza; S Melethil; S Berger; E C Ernst
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

5.  Increased temperature enhances the antimicrobial effects of daptomycin, vancomycin, tigecycline, fosfomycin, and cefamandole on staphylococcal biofilms.

Authors:  Stefan Hajdu; Johannes Holinka; Sonja Reichmann; Alexander M Hirschl; Wolfgang Graninger; Elisabeth Presterl
Journal:  Antimicrob Agents Chemother       Date:  2010-08-02       Impact factor: 5.191

6.  Saturation of the tubular excretion of beta-lactam antibiotics.

Authors:  J W Bins; H Mattie
Journal:  Br J Clin Pharmacol       Date:  1988-01       Impact factor: 4.335

7.  Human pharmacology of cefotaxime (HR 756), a new cephalosporin.

Authors:  R Lüthy; R Münch; J Blaser; H Bhend; W Siegenthaler
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

8.  The pharmacokinetics of cefuroxime after intravenous injection.

Authors:  P E Gower; C H Dash
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

9.  Comparison of cephalothin and cefamandole prophylaxis during insertion of prosthetic heart valves.

Authors:  G L Archer; R E Polk; R J Duma; R Lower
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

10.  Pharmacokinetics of cefamandole in the presence of renal failure in patients undergoing hemodialysis.

Authors:  G B Appel; H C Neu; M F Parry; M J Goldberger; G B Jacob
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.